All work
Purity. Proven.
Rebranding a strategic business unit for growth following its acquisition
All work
Rebranding a strategic business unit for growth following its acquisition
After decades operating as FeF Chemicals, Novo Nordisk Pharmatech had evolved into a specialised pharmaceutical business within the Novo Nordisk group. To strengthen its market position, the company chose to align more closely with the Novo Nordisk brand. CBC led the rebranding, developing a new identity and creative platform for internal and external communications.
Since 1949, Novo Nordisk Pharmatech whas been creating pharmaceutical ingredients by Køge Bay in Denmark. What started as FeF Chemicals, a small chemistry factory, would later become a valuable subsidiary of Novo Nordisk, enabling some of the greatest pharmaceutical discoveries and treatments.
CBC created a strong value proposition and identity under the concept ‘Excellence. Multiplied.’. This conveyed the company’s dedication to quality across hundreds of products as well as the purity and precision of its processes.
As a central marketing piece, a new website was created from scratch, from structure, content plans and wireframes through to content production, technical implementation and testing.
An internal launch campaign was developed to help staff understand the thinking and strategy behind the rebranding process through a series of engagement activities.
The visual identity and messaging transitioned perfectly to a trade show environment.
Novo Nordisk Pharmatech is a business unit within the Novo Nordisk group and a leading global supplier of high-quality pharma ingredients.
It was originally an independent company known as FeF Chemicals, established in 1949 and acquired by Novo Nordisk in 1986.
As FeF Chemicals evolved, management decided to bring in CBC for a major rebranding project to develop a new company name, identity and creative platform for internal and external communications channels.
Learn more about: